150.51 USD
↘ 0.99 (0.65%)LIVE (AS OF 09:37 AM EDT)
Protagonist Therapeutics, Inc
PTGXNASDAQ • USD
Market: OPEN
Shares of Protagonist Therapeutics, Inc (PTGX) are trading at $150.51. The technical outlook is "Buy" and the fundamental picture shows "Neutral". Notable factors include a robust Altman Z-Score, a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Aug 26, 2026.
Open?$151.31
High?$153.09
Low?$147.91
Prev. Close?$151.50
Volume?8.1K
Avg. Volume?514.3K
VWAP?$150.41
Rel. Volume?0.02x
Bid / Ask
Bid?$124.70 × 100
Ask?$173.28 × 100
Spread?$48.58
Midpoint?$148.99
Valuation & Ratios
Market Cap?9.8B
Shares Out?64.7M
Float?58.7M
Float %?90.8%
P/E Ratio?118.24
P/B Ratio?11.65
EPS?$1.28
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.
Themes
Employees
141
Market Cap
9.8B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2016-08-11
Address
7707 GATEWAY BLVD., SUITE 140
NEWARK, CA 94560-1160
Phone: (510) 474-0170
NEWARK, CA 94560-1160
Phone: (510) 474-0170
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?40
Z-Score?100
Momentum?90
Short Sent.?28
Piotroski F-Score?4/9Mixed
Altman Z-Score?134.78Safe
Confidence?58%Low
Short InterestVery High
Short % of Float?13.26%High
Short Interest?7.8M
Days to Cover?16.4
Free Float58.7M
Avg Daily Volume474.6K
Settlement Date2026-08-14
Financial Health
Current Ratio?21.71Strong
Quick Ratio?21.71Strong
Cash Ratio?11.30Strong
Debt/Equity?0.00Low
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score33/100
P/E?118.2PRICEY▾
Peers100
S&P3
P/B?11.65HIGH▾
Peers100
S&P17
P/S?34.76HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?157.7HIGH▾
Peers100
S&P3
EV/Sales?33.27HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?9.9%FAIR▾
Peers50
S&P34
ROA?9.4%STRONG▾
Peers50
S&P72
Cash Flow & Enterprise
FCF?$-88302000
Enterprise Value?$9.4B
Fundamentals ratios updated end of day